Accumulation of aggregated Aβ in the AD brain has been reported to disrupt calcium metabolism with concomitant downstream cytotoxic effects such as mitochondrial dysfunction, activation of caspases [64,65] microtubule destabilisation and tau phosphorylation [66]. This evidence concerns the gene MAPT and Alzheimer disease.